Literature DB >> 7529986

Immunoblotting detection of so-called 'antikeratin antibodies': a new assay for the diagnosis of rheumatoid arthritis.

V Gomès-Daudrix1, M Sebbag, E Girbal, C Vincent, M Simon, J Rakotoarivony, M Abbal, B Fournié, G Serre.   

Abstract

OBJECTIVES: To assess the diagnostic value for rheumatoid arthritis (RA), of an immunoblotting assay based on the rat oesophagus epithelium antigens recognised by the so-called 'antikeratin antibodies' ('AKA'), antigens that have been identified as three non-cytokeratin proteins (referred to as A, B and C proteins).
METHODS: After polyacrylamide gel electrophoresis in non-denaturing conditions and electrotransfer of an epithelial extract, the immunoreactivities to the A, B and C proteins of a series of serum samples from 88 patients with RA and 100 patients with non-rheumatoid rheumatic diseases, were semiquantitatively evaluated.
RESULTS: A total of 81.8% of RA serum samples recognised the three proteins, while 91% of non-RA serum samples only weakly recognised the A and B proteins but not the C protein. Only in the group of RA patients, were the titres of the antibodies to the A, B and C proteins found to be significantly correlated with each other and with the titres of 'AKA' detected by the standard indirect immunofluorescence (IIF) method. For a diagnostic specificity of 99%, the diagnostic sensitivities of the detection of the A and B proteins were 50% and 43.2%, respectively, when those of the detection of 'AKA' by IIF and of IgM-rheumatoid factor by enzyme-linked immunosorbent assay were 42% and 54%, respectively. In contrast, at a same specificity of 99%, the diagnostic sensitivity of the detection of the C protein was significantly higher with a value of 70.5%.
CONCLUSION: This immunoblotting assay which is the first immunochemical method proposed for the detection of 'AKA, should be validated on larger series of patients but can already be considered as a very powerful test for the serological diagnosis of RA.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529986      PMCID: PMC1005454          DOI: 10.1136/ard.53.11.735

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  32 in total

1.  Development and comparative evaluation of immunoblot assays for detecting autoantibodies to Scl 70 and Jo 1 antigens in serum.

Authors:  T Fonong; S M Evans; H A Homburger
Journal:  Clin Chem       Date:  1990-12       Impact factor: 8.327

2.  Natural IgM and IgG autoantibodies to epidermal keratins in normal human sera. I: ELISA-titration, immunofluorescence study.

Authors:  G Serre; C Vincent; R Viraben; J P Soleilhavoup
Journal:  J Invest Dermatol       Date:  1987-01       Impact factor: 8.551

3.  Autoantibodies to lamins in rheumatoid arthritis.

Authors:  S Lassoued; F Oksman; B Fournie; F Danon; A Fournie; K Lassoued
Journal:  Arthritis Rheum       Date:  1990-06

4.  Antikeratin antibodies in rheumatoid arthritis. Methods and clinical significance.

Authors:  H Kirstein; F K Mathiesen
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

5.  [Anti-stratum corneum antibody in the rat esophagus, anti-epidermal keratin and anti-epidermis autoantibodies in rheumatoid polyarthritis and other rheumatic diseases. Diagnostic value and basic aspects].

Authors:  G Serre; C Vincent; B Fournié; F Lapeyre; J P Soleilhavoup; A Fournié
Journal:  Rev Rhum Mal Osteoartic       Date:  1986-11

6.  [Anti-keratin antibodies. A marker of progressive rheumatoid arthritis].

Authors:  O Meyer; D Fabregas; L Cyna; A Ryckewaert
Journal:  Rev Rhum Mal Osteoartic       Date:  1986-11

7.  The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis.

Authors:  F C Arnett; S M Edworthy; D A Bloch; D J McShane; J F Fries; N S Cooper; L A Healey; S R Kaplan; M H Liang; H S Luthra
Journal:  Arthritis Rheum       Date:  1988-03

8.  High diagnostic value in rheumatoid arthritis of antibodies to the stratum corneum of rat oesophagus epithelium, so-called 'antikeratin antibodies'.

Authors:  C Vincent; G Serre; F Lapeyre; B Fournié; C Ayrolles; A Fournié; J P Soleilhavoup
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

9.  Specificity of antibodies to type II collagen in rheumatoid arthritis.

Authors:  K Terato; Y Shimozuru; K Katayama; Y Takemitsu; I Yamashita; M Miyatsu; K Fujii; M Sagara; S Kobayashi; M Goto
Journal:  Arthritis Rheum       Date:  1990-10

10.  Altered immune response to glycine-rich sequences of Epstein-Barr nuclear antigen-1 in patients with rheumatoid arthritis and systemic lupus erythematosus.

Authors:  J Petersen; G Rhodes; J Roudier; J H Vaughan
Journal:  Arthritis Rheum       Date:  1990-07
View more
  9 in total

Review 1.  [Rheumatology update. Current knowledge of etiology, pathophysiology, diagnosis, and therapy of selected arthritic disorders. Part I: pathogenesis and differential diagnosis].

Authors:  G Hein; P Oelzner; H Sprott; B Manger
Journal:  Med Klin (Munich)       Date:  1999-09-15

Review 2.  Anti-citrullinated peptide antibody assays and their role in the diagnosis of rheumatoid arthritis.

Authors:  Rohit Aggarwal; Katherine Liao; Raj Nair; Sarah Ringold; Karen H Costenbader
Journal:  Arthritis Rheum       Date:  2009-11-15

3.  The antiperinuclear factor and the so-called antikeratin antibodies are the same rheumatoid arthritis-specific autoantibodies.

Authors:  M Sebbag; M Simon; C Vincent; C Masson-Bessière; E Girbal; J J Durieux; G Serre
Journal:  J Clin Invest       Date:  1995-06       Impact factor: 14.808

4.  IgG subclass distribution of the rheumatoid arthritis-specific autoantibodies to citrullinated fibrin.

Authors:  S Chapuy-Regaud; L Nogueira; C Clavel; M Sebbag; C Vincent; G Serre
Journal:  Clin Exp Immunol       Date:  2005-03       Impact factor: 4.330

5.  Anti-perinuclear factor compared with the so called "antikeratin" antibodies and antibodies to human epidermis filaggrin, in the diagnosis of arthritides.

Authors:  C Vincent; F de Keyser; C Masson-Bessière; M Sebbag; E M Veys; G Serre
Journal:  Ann Rheum Dis       Date:  1999-01       Impact factor: 19.103

6.  Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis.

Authors:  L Nogueira; M Sebbag; C Vincent; M Arnaud; B Fournié; A Cantagrel; M Jolivet; G Serre
Journal:  Ann Rheum Dis       Date:  2001-09       Impact factor: 19.103

Review 7.  Autoantibodies to posttranslational modifications in rheumatoid arthritis.

Authors:  Agata N Burska; Laura Hunt; Marjorie Boissinot; Rocky Strollo; Brent J Ryan; Ed Vital; Ahuva Nissim; Paul G Winyard; Paul Emery; Frederique Ponchel
Journal:  Mediators Inflamm       Date:  2014-03-23       Impact factor: 4.711

8.  Decreased severity of experimental autoimmune arthritis in peptidylarginine deiminase type 4 knockout mice.

Authors:  Akari Suzuki; Yuta Kochi; Hirofumi Shoda; Yu Seri; Keishi Fujio; Tetsuji Sawada; Ryo Yamada; Kazuhiko Yamamoto
Journal:  BMC Musculoskelet Disord       Date:  2016-05-05       Impact factor: 2.362

9.  Circulation autoantibody against Lamin A/C in patients with Sjögren's syndrome.

Authors:  Wen Zhang; Chunyan Zhang; Peng Chen; Chunhe Yang; Xianfeng Gan; Muhammad Hussain; Yiping Xun; Yaping Tian; Hongwu Du
Journal:  Oncotarget       Date:  2016-12-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.